Find Grants for School Districts
Find out if you qualify for verified grants for School Districts. Discover your eligibility and key funding details for School Districts from major foundations and government agencies.
NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required)
Deadline: March 6, 2026
Opportunity Number: PAR-25-049
Agency: National Institutes of Health
Open Date: November 7, 2024
Close Date: March 6, 2026
Status: Posted
CFDA Numbers: 93.853
NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-234
Agency: National Institutes of Health
Open Date: November 7, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.853
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
Deadline: January 7, 2027
Opportunity Number: PAR-25-079
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.395, 93.394
Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)
Deadline: May 7, 2026
Opportunity Number: PAR-25-063
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.242
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
Deadline: September 7, 2026
Opportunity Number: PAR-25-153
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.395
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
Deadline: September 7, 2027
Opportunity Number: PAR-24-325
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.866, 93.867, 93.286, 93.395, 93.394
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-145
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.393
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)
Deadline: May 7, 2026
Opportunity Number: PAR-25-036
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.866, 93.242
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-175
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.393, 93.395, 93.394
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-24-311
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.394, 93.395, 93.396
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)
Deadline: November 12, 2027
Opportunity Number: PAR-24-321
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: November 12, 2027
Status: Posted
CFDA Numbers: 93.866
Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-227
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.865
Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
Deadline: January 7, 2027
Opportunity Number: PAR-25-221
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.396, 93.273
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)
Deadline: September 7, 2026
Opportunity Number: PAR-24-306
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.393, 93.395, 93.396, 93.394
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
Deadline: January 6, 2028
Opportunity Number: PAS-25-205
Agency: National Institutes of Health
Open Date: November 6, 2024
Close Date: January 6, 2028
Status: Posted
CFDA Numbers: 93.839, 93.847, 93.866
BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
Deadline: September 28, 2026
Opportunity Number: RFA-NS-25-021
Agency: National Institutes of Health
Open Date: November 5, 2024
Close Date: September 28, 2026
Status: Posted
CFDA Numbers: 93.866, 93.867, 93.242, 93.213, 93.865, 93.173, 93.853, 93.286, 93.273, 93.279
BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
Deadline: September 28, 2026
Opportunity Number: RFA-NS-25-022
Agency: National Institutes of Health
Open Date: November 5, 2024
Close Date: September 28, 2026
Status: Posted
CFDA Numbers: 93.866, 93.867, 93.286, 93.279, 93.865, 93.853, 93.273, 93.173, 93.213, 93.242
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
Deadline: October 25, 2027
Opportunity Number: PAR-25-104
Agency: National Institutes of Health
Open Date: November 5, 2024
Close Date: October 25, 2027
Status: Posted
CFDA Numbers: 93.399
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
Deadline: October 25, 2027
Opportunity Number: PAR-25-103
Agency: National Institutes of Health
Open Date: November 5, 2024
Close Date: October 25, 2027
Status: Posted
CFDA Numbers: 93.399
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
Deadline: October 20, 2027
Opportunity Number: PAR-25-225
Agency: National Institutes of Health
Open Date: November 4, 2024
Close Date: October 20, 2027
Status: Posted
CFDA Numbers: 93.853
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
Deadline: October 16, 2026
Opportunity Number: PAR-25-077
Agency: National Institutes of Health
Open Date: November 1, 2024
Close Date: October 16, 2026
Status: Posted
CFDA Numbers: 93.853, 93.855
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-143
Agency: National Institutes of Health
Open Date: October 31, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.279, 93.242, 93.273, 93.989, 93.307, 93.172, 93.866, 93.399, 93.846, 93.361, 93.173, 93.121, 93.113, 93.855, 93.865, 93.213, 93.853, 93.310
Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
Deadline: January 7, 2028
Opportunity Number: PAR-25-207
Agency: National Institutes of Health
Open Date: October 31, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
Deadline: June 2, 2027
Opportunity Number: PAR-25-210
Agency: National Institutes of Health
Open Date: October 31, 2024
Close Date: June 2, 2027
Status: Posted
CFDA Numbers: 93.866, 93.313, 93.393, 93.213, 93.121
Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)
Deadline: June 2, 2027
Opportunity Number: PAR-25-211
Agency: National Institutes of Health
Open Date: October 31, 2024
Close Date: June 2, 2027
Status: Posted
CFDA Numbers: 93.393, 93.121, 93.213, 93.313, 93.866
